Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ASCO 2016
ASCO 2016
AbbVie's New Lung Cancer Drug May Extend Patients' Lives, But Could Disappoint Investors
Forbes
Sun, 06/5/16 - 11:50 am
AbbVie
Rova-T
non-small cell lung cancer
ASCO 2016
Juno Therapeutics’ Defined Composition CD19 Product Candidates Demonstrate Encouraging Clinical Outcomes and Tolerability
Yahoo
Sun, 06/5/16 - 11:48 am
Juno Therapeutics
CD19
CAR-T
ASCO 2016
B-cell malignancies
Five Prime Therapeutics Announces Updated Data in Mesothelioma Patients from Ongoing Phase 1b Trial of FP-1039 Presented at 2016 ASCO Annual Meeting
Yahoo
Sat, 06/4/16 - 06:27 pm
Five Prime
ASCO 2016
mesothelioma
FP-1039
Pfizer Presents Data from Phase 1b Trial Investigating Utomilumab (a 4-1BB agonist) in Combination with a Checkpoint Inhibitor
Yahoo
Sat, 06/4/16 - 06:19 pm
Pfizer
ASCO 2016
utomilumab
Pembrolizumab
Kite Pharma rides CAR-T momentum into ASCO
BioPharma Dive
Fri, 06/3/16 - 09:46 pm
ASCO 2016
Kite Pharma
CAR-T
Immunotherapy At ASCO: The Cancer Research Institute On What To Watch
Forbes
Fri, 06/3/16 - 10:43 am
ASCO 2016
cancer immunotherapy
Immunomedics Kicked Out of Prestigious ASCO Cancer Conference
TheStreet.com
Fri, 06/3/16 - 09:49 am
Immunomedics
triple negative breast cancer
ASCO 2016
IMMU-132
What You Need to Know About the World's Biggest Cancer Conference
Fortune
Thu, 06/2/16 - 03:52 pm
ASCO 2016
cancer
Five Storylines To Watch At ASCO
Forbes
Tue, 05/31/16 - 11:14 am
ASCO 2016
drug pricing
Pfizer
Ibrance
breast cancer
Tecentriq
Genentech
Roche
PDL-1 inhibitors
3 Stories To Watch At The Year’s Biggest Cancer Conference
Investors.com
Mon, 05/30/16 - 06:34 pm
ASCO 2016
Pfizer
Eli Lilly
breast cancer
Ibrance
abemaciclib
AbbVie
non-small cell lung cancer
Rova-T
Keytruda
Bristol-Myers Squibb
Merck
Opdivo
Here are 13 MA cancer biotechs hoping to make waves next month
Bizjournals.com
Fri, 05/20/16 - 11:36 am
Boston
biotech
ASCO 2016
Ariad Pharmaceuticals
Immunogen
Ziopharm
Vertex Pharmaceuticals
Tokai
Infinity Pharmaceuticals
Momenta
Merrimack
Tesaro
Syndax
Kyropharm
Foundation Medicine
Cerulean Pharma
Merck, Bristol drugs show longer survival for deadly cancers
Yahoo/Reuters
Thu, 05/19/16 - 09:59 am
Merck
Bristol-Myers Squibb
cancer immunotherapy
lung cancer
melanoma
Opdivo
Keytruda
ASCO 2016
Pages
« first
‹ previous
1
2